We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+19.35%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.4B
AUM Growth
+$10.3B
(+15%)
Cap. Flow
-$1.63B
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
17.35%
Holding
1,869
New
81
Increased
811
Reduced
837
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$355M |
| 2 |
Yum China
YUMC
|
+$307M |
| 3 |
Elanco Animal Health
ELAN
|
+$298M |
| 4 |
Western Midstream Partners
WES
|
+$238M |
| 5 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$137M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$291M |
| 2 |
PepsiCo
PEP
|
+$260M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$258M |
| 4 |
Apple
AAPL
|
+$221M |
| 5 |
WES
Western Gas Partners Lp
WES
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.81% |
| 2 | Technology | 15.13% |
| 3 | Energy | 13.68% |
| 4 | Healthcare | 13.59% |
| 5 | Financials | 12.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Chubb
CB
$133B
| $46.4M | 0.06% |
331,371
-141,547
| -30% | -$18.8M |
|
327
Bristol-Myers Squibb
BMY
$124B
| $46.4M | 0.06% |
972,307
-655,354
| -40% | -$32.6M |
|
328
Parker-Hannifin
PH
$122B
| $46.4M | 0.06% |
270,200
-54,251
| -17% | -$9M |
|
|
RDS.A
329
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $45.8M | 0.06% |
732,282
-337,030
| -32% | -$20.8M |
|
330
Broadcom
AVGO
$1.89T
| $45.6M | 0.06% |
1,517,420
+1,530
| +0.1% | +$41.5K |
|
|
GTLS
331
DELISTED
Chart Industries
GTLS
| $45.5M | 0.06% |
502,635
+51,918
| +12% | +$4.19M |
|
332
Paylocity
PCTY
$6.47B
| $45.4M | 0.06% |
509,082
-17,591
| -3% | -$1.37M |
|
333
Stryker
SYK
$119B
| $45.1M | 0.06% |
228,446
+14,247
| +7% | +$2.56M |
|
334
Humana
HUM
$47.7B
| $45.1M | 0.06% |
169,408
-6,633
| -4% | -$1.91M |
|
335
TSMC
TSM
$2.18T
| $44.6M | 0.06% |
1,090,044
+185,601
| +21% | +$7.08M |
|
336
Oneok
OKE
$57.8B
| $44.4M | 0.06% |
636,136
+121,818
| +24% | +$7.89M |
|
|
GWR
337
DELISTED
Genesee & Wyoming Inc.
GWR
| $44.2M | 0.06% |
507,286
-22,706
| -4% | -$1.84M |
|
|
BBBY
338
DELISTED
Bed Bath & Beyond Inc
BBBY
| $44.2M | 0.05% |
2,600,532
+2,355,487
| +961% | +$35.6M |
|
339
CoStar Group
CSGP
$11.3B
| $43.9M | 0.05% |
942,110
-354,290
| -27% | -$14.6M |
|
340
SL Green Realty
SLG
$3.56B
| $43.8M | 0.05% |
503,303
+22,794
| +5% | +$1.98M |
|
341
Veeco
VECO
$3.33B
| $43.7M | 0.05% |
4,027,631
-12,069
| -0.3% | -$124K |
|
|
KSU
342
DELISTED
Kansas City Southern
KSU
| $43.6M | 0.05% |
376,269
-78,270
| -17% | -$8.45M |
|
343
Coty
COTY
$2.4B
| $43.6M | 0.05% |
3,791,689
+3,688,556
| +3,577% | +$34.9M |
|
344
Live Nation Entertainment
LYV
$41.4B
| $43.4M | 0.05% |
683,307
+99,353
| +17% | +$5.63M |
|
345
TJX Companies
TJX
$172B
| $43.2M | 0.05% |
812,771
+173,492
| +27% | +$8.65M |
|
346
American Electric Power
AEP
$72.4B
| $43M | 0.05% |
513,946
-196,223
| -28% | -$15.6M |
|
347
Matador Resources
MTDR
$6.83B
| $42.4M | 0.05% |
2,191,391
-207,622
| -9% | -$3.87M |
|
|
EFOR
348
Everforth Inc
EFOR
$836M
| $41.6M | 0.05% |
655,539
+15,984
| +2% | +$999K |
|
349
Lam Research
LRCX
$399B
| $41.5M | 0.05% |
2,320,650
+1,910,220
| +465% | +$31.9M |
|
350
Principal Financial Group
PFG
$23.4B
| $41.4M | 0.05% |
824,999
+789,924
| +2,252% | +$39.2M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2019 Portfolio in Review
As of Q1 2019, OppenheimerFunds held 1,869 positions worth $80.4B, up 15% from $70.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
OppenheimerFunds's Q1 2019 filing shows 81 new, 811 increased, 837 reduced and 124 closed positions. Its largest new stake was Elanco Animal Health: 9,668,160 shares worth $310M. The largest sale was Pinduoduo, an estimated $291M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Technology and Energy.
- OppenheimerFunds's largest Q1 2019 buy was Elanco Animal Health: 9,668,160 shares worth $310M.
- OppenheimerFunds added most to Procter & Gamble in Q1 2019, an estimated $355M increase.
- OppenheimerFunds's biggest Q1 2019 reduction was Pinduoduo, cutting an estimated $291M.
- OppenheimerFunds fully exited Western Gas Partners Lp in Q1 2019, selling an estimated $215M.
- OppenheimerFunds's ten largest holdings make up 17% of its $80.4B portfolio in Q1 2019.
- OppenheimerFunds opened 81 new positions and closed 124 in Q1 2019.
- OppenheimerFunds's portfolio value rose 15% quarter-over-quarter to $80.4B.
Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.